Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
FDA accelerated approval of anticancer agents. Background: Investigator-initiated trials (IITs) are the backbone of cancer center (CC) clinical programs. They are essential to early testing of drug ...
Like much of the industry, Union Pacific’s fourth-quarter and full-year 2023 results reflected growing momentum in the year’s final quarter and into what promises to be a stronger 2024. While ...
MINNEAPOLIS, Jan. 14, 2020 (GLOBE NEWSWIRE) -- New research shows 40% of enterprise IT teams report low productive resource utilization and 33% of professional services (PS/CS) teams have low billable ...
Differences in uptake of postoperative adjuvant chemotherapy for lung cancer: Results from the Project for an Ontario Women's Health Evidence-Based Report Card (POWER) study ...
Monique Danao is a highly experienced journalist, editor, and copywriter with an extensive background in B2B SaaS technology. Her work has been published in Forbes Advisor, Decential, Canva, 99Designs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results